Capsazepine activates amiloride-insensitive ENaC-like channels in human leukemia cells
Biochemical and Biophysical Research Communications · 2023
DOI: 10.1016/j.bbrc.2023.149187 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biochemical and Biophysical Research Communications, 2023. Verfasst von Daria V Lysikova und 4 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Cytology, Russian Academy of Sciences, 194064 Tikhoretsky Ave. 4, St. Petersburg, Russia. Hauptthemen laut MEDLINE: Amiloride, Leukemia, Myeloid. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 57 Literaturangaben. Gefördert von: Ministry of Education and Science of the Russian Federation, Russian Science Foundation.
Abstract (Originalsprache)
Sodium influx carried out by ion channels is one of the main regulators of water-salt and volume balance in cells of blood origin. Previously, we described amiloride-insensitive ENaC-like channels in human myeloid leukemia K562 cells; the intracellular regulatory mechanisms of the channels are associated with actin cytoskeleton dynamics. Recently, an extracellular mechanism of ENaC-like channels activation in K562 cells by the action of serine protease trypsin has been revealed. The other extracellular pathways that modulate ENaC (epithelial Na+ channel) activity and sodium permeability in transformed blood cells are not yet fully investigated. Here, we study the action of capsazepine (CPZ), as δ-ENaC activator, on single channel activity in K562 cells in whole-cell patch clamp experiments. Addition of CPZ (2 μM) to the extracellular solution caused an activation of sodium channels with typical features; unitary conductance was 15.1 ± 0.8 pS. Amiloride derivative benzamil (50 μM) did not inhibit their activity. Unitary currents and conductance of CPZ-activated channels were higher in Na+-containing extracellular solution than in Li+, that is one of the main fingerprints of δ-ENaC. The results of RT-PCR analysis and immunofluorescence staining also confirmed the expression of δ-hENaC (as well as α-, β-, γ-ENaC) at the mRNA and protein level. These findings allow us to speculate that CPZ activates amiloride-insensitive ENaC-like channels that contain δ-ENaC in К562 cells. Our data reveal a novel extracellular mechanism for ENaC-like activation in human leukemia cells.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Cytology, Russian Academy of Sciences, 194064 Tikhoretsky Ave. 4, St. Petersburg, Russia.
- Institute of Cytology, Russian Academy of Sciences, 194064 Tikhoretsky Ave. 4, St. Petersburg, Russia. Electronic address: anastasia.sudarikova@gmail.com.
Förderung
- Ministry of Education and Science of the Russian Federation
- Russian Science Foundation
Zitieren
APA
Lysikova, D. V., Vasileva, V. Y., Chubinskiy-Nadezhdin, V. I., Morachevskaya, E. A., & Sudarikova, A. V. (2023). Capsazepine activates amiloride-insensitive ENaC-like channels in human leukemia cells. Biochemical and Biophysical Research Communications. https://doi.org/10.1016/j.bbrc.2023.149187
Vancouver
Lysikova DV, Vasileva VY, Chubinskiy-Nadezhdin VI, Morachevskaya EA, Sudarikova AV. Capsazepine activates amiloride-insensitive ENaC-like channels in human leukemia cells. Biochemical and Biophysical Research Communications. 2023. doi:10.1016/j.bbrc.2023.149187
BibTeX
@article{Lysikova2023,
author = {Lysikova, Daria V and Vasileva, Valeria Y and Chubinskiy-Nadezhdin, Vladislav I and Morachevskaya, Elena A and Sudarikova, Anastasia V},
title = {Capsazepine activates amiloride-insensitive ENaC-like channels in human leukemia cells},
journal = {Biochemical and Biophysical Research Communications},
year = {2023},
doi = {10.1016/j.bbrc.2023.149187}
}
EUVIMED